Reversal of microvascular rarefaction and reduced renal mass hypertension

Hypertension

Volumn 30, Issue 1, 1997, Pages 120-127

  Rieder, Mark J ^a   Roman, Richard J ^a   Greene, Andrew S ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Angiotensin converting enzyme; Hypertension, renal; Renin angiotensin system; Sodium

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; KIDNEY BLOOD FLOW; MALE; NONHUMAN; PATHOPHYSIOLOGY; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION; SODIUM TRANSPORT;

EID: 0030741531     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.1.120     Document Type: Article

References (39)

1. Hutchins PM, Darnell AE. Observation of a decreased number of small arterioles in spontaneously hypertensive rats. Circ Res. 1974; 34/35(suppl I):I-161-I-165.
2. Chen IIH, Prewitt RL, Dowell RF. Microvascular rarefaction in spontaneously hypertensive rat cremaster muscle. Am J Physiol. 1981;241:H306-H310.
3. Bohlen HG. Intestinal microvascular adaptation during maturation of spontaneously hypertensive rats. Hypertension. 1983;5:739-745.
4. Prewitt RL, Chen IIH, Dowell RF. Microvascular alterations in the one kidney, one-clip renal hypertensive rat. Am J Physiol. 1984;246: H728-H732.
5. Stacy DL, Prewitt RL. Attenuated microvascular alterations in coarctation hypertension. Am J Physiol. 1989;256:H213-H221.
6. Sullivan JM, Prewitt RL, Josephs JA. Attenuation of the microcirculation in young patients with high-output borderline hypertension. Hypertension. 1983;5:844-851.
7. Henrich HA, Romen W, Heimgärtner W, Hartung E, Bäumer F. Capillary rarefaction characteristic of the skeletal muscle of hypertensive patients. Klin Wochenschr. 1988;66:54-60.
8. Motz W, Strauer BE. Therapy of hypertensive cardiac hypertrophy and impaired coronary microcirculation. J Cardiovasc Pharmacol. 1994;24(suppl 1):S34-S38.
9. Munzenmaier DH, Greene AS. Opposing actions of angiotensin II on microvascular growth and arterial blood pressure. Hypertension. 1996;27(part 2):760-765.
10. Hernandez I, Cowley AW, Lombard JH, Greene AS. Salt intake and angiotensin II alter microvessel density in the cremaster muscle of normal rats. Am J Physiol. 1992;263:H664-H667.
11. Hernandez I, Greene AS. Hemodynamic and microcirculatory changes during development of renal hypertension. Am J Physiol. 1995;268:H33-H38.
12. Prewitt RL, Chen IIH, Dowell RF. Development of microvascular rarefaction in the spontaneously hypertensive rat. Am J Physiol. 1982;243:H243-H251.
13. Thurston H, Bing RF, Swales JD. Reversal of two-kidney one clip renovascular hypertension in the rat. Hypertension. 1980;2:256-265.
14. Russell GI, Bing RF, Swales JD, Thurston H. Hemodynamic changes induced by reversal of early and late renovascular hypertension. Am J Physiol. 1983;245:H734-H740.
15. Swales JD, Bing RF, Russell GI, Thurston H. Reversal of renovascular hypertension. Clin Exp Pharmacol Physiol. 1983; 10: 239-251.
16. Godfrey N, Kumar A, Bing RF, Swales JD, Thurston H. Reversal of renovascular hypertension: a comparison of changes in blood pressure, plasma renin, and sodium balance in two models in rats. J Lab Clin Med. 1985;105:679-685.
17. Cowley AW, Skelton MM, Papanek PE, Greene AS. Hypertension induced by high salt intake in absence of volume retention in reduced renal mass rats. Am J Physiol. 1994;267:H1707-H1712.
18. Greene AS, Lombard JH, Cowley AW, Hansen-Smith FM. Microvessel changes in hypertension measured by Griffonia simplidfolia I lectin. Hypertension. 1990;15:779-783.
19. Hansen-Smith FM, Greene AS, Cowley AW, Lombard JH. Structural changes during microvascular rarefaction in chronic hypertension. Hypertension. 1990;15:922-928.
20. Lombard JH, Hinojosa-Laborde C, Cowley AW. Hemodynamics and microcirculatory alterations in reduced renal mass hypertension. Hypertension. 1989;13:128-138.
21. Rieder MJ, O'Drobinak DM, Greene AS. A computerized method for determination of microvascular density. Microvasc Res. 1995;49: 180-189.
22. Sealey JE, Laragh JH. How to do a plasma renin assay. Cardiovasc Med. 1977;2:1079-1092.
23. Santos RAS, Krieger EM, Greene LJ. An improved fluorometric assay of rat serum and plasma converting enzyme. Hypertension. 1985;7:244-252.
24. Boegehold MA, Johnson MD, Overbeck HW. Pressure independent arteriolar rarefaction in hypertension. Am J Physiol. 1991; 261:H83-H87.
25. Hogan RD, Hirschmann L. Arteriolar proliferation in the rat cremaster muscle as a long term autoregulatory response to reduced perfusion. Microvasc Res. 1984;27:290-296.
26. Ono Z, Prewitt RL, Stacy DL. Arteriolar changes in developing and chronic stages of two-kidney, one-clip hypertension. Hypertension. 1989;14:36-43.
27. Wang DH, Prewitt RL. Captopril reduces aortic and microvascular growth in hypertensive and normotensive rats. Hypertension. 1990; 15:68-77.
28. Kanagy NL, Fink GD. Losartan prevents salt-induced hypertension in reduced renal mass rats. J Pharmacol Exp Ther. 1993;265: 1131-1136.
29. Meyer TW, Anderson S, Rennke HG, Brenner BM. Converting enzyme inhibitor therapy limits progressive glomerular injury in rats with renal insufficiency. Am J Med. 1985;79(suppl 3C):31-36.
30. Brooks DP, Contino LC, Trizna W, Edwards RM, Ohlstein EH, Solleveld HA. Effect of enalapril or the thromboxane receptor antagonist, daltroban, in rats with subtotal ablation. J Pharmacol Exp Ther. 1990;253:119-123.
31. Liard JF. Regional blood flows in salt loading hypertension in the dog. Am J Physiol. 1981;240:H361-H367.
32. Schunkert H, Ingelfinger JR, Hirsch AT, Pinto Y, Remme WJ, Jacob H, Dzau VJ. Feedback regulation of angiotensin converting enzyme activity and mRNA levels by angiotensin II. Circ Res. 1993;72:312-318.
33. Kohara K, Broshnihan KB, Ferrario CM, Milsted A. Peripheral and central angiotensin II regulates expression of genes of the renin-angiotensin system. Am J Physiol. 1992;262:E651-E657.
34. Wood JM, Jobber RA, Baum HP, Gasparo M, Nussberger J. Biochemical effects of prolonged renin inhibition in marmosets. J Hypertens. 1989;7:615-618.
35. Santos RAS, Greene LJ, Krieger EM. Changes in plasma ACE activity during the development and reversal of one-kidney, one clip hypertension in rats. Clin Exp Hypertens A. 1989;11:189-203.
36. Du Y, Yao A, Guo D, Inagami T, Wang DH. Differential regulation of angiotensin II receptor subtypes in rat kidney by low dietary sodium. Hypertension. 1995;25(part 2):872-877.
37. Greene AS, Tonellato PJ, Zhang Z, Lombard JH, Cowley AW. Effect of microvascular rarefaction on tissue oxygen delivery in hypertension. Am J Physiol. 1992;262:H1486-H1493.
38. Ylitalo P, Hepp R, Mohring J, Gross F. Effects of varying sodium intake on blood pressure and renin-angiotensin system in subtotally nephrectomized rats. J Lab Clin Med. 1976;88:807-816.
39. Langstrom JB, Guyton AC, Douglass BH, Dorsett PE. Effect of changes in salt intake on arterial pressure and renal function in partially nephrectomized dogs. Circ Res. 1963;12:508-513.